Abstract:Schizophrenia and related mood disorders are complex psychiatric disorders that affect ~2% of the population ( 1 Brandon N.J. Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011; 12: 707-722 Google Scholar , 2 Moghaddam B. Javitt D. From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012; 37: 4-15 Google Scholar ). The fortuitous finding of chlorpromazine and other phenothiazines in the early 1950s and subsequent development of clozapine and related antipsychotic drugs ameliorated a subset of syndromes of psychosis and resulted in deinstitutionalization of many patients with psychiatric disorders. The drugs seem to benefit patients by modulating dopaminergic or serotoninergic function, or both. The exact mechanisms of action of the drugs are unknown. There are still no good answers 50 years after the discovery of these drugs as to why the medications fail to treat the negative symptoms and cognitive deficits, and this lack of answers has hampered the development of more effective medications ( 1 Brandon N.J. Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011; 12: 707-722 Google Scholar , 2 Moghaddam B. Javitt D. From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012; 37: 4-15 Google Scholar ). A comprehensive understanding of the etiopathology of psychiatric disorders is urgently needed for developing improved medications. Accumulating research findings have fostered a hypothesis that aberrant glutamatergic transmission, particularly aberrant N-methyl-D-aspartate receptor (NMDAR)–mediated glutamate transmission, may be responsible for schizophrenia and related psychiatric disorders ( 1 Brandon N.J. Sawa A. Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci. 2011; 12: 707-722 Google Scholar , 2 Moghaddam B. Javitt D. From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology. 2012; 37: 4-15 Google Scholar , 3 Harrison P.J. Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry. 2005; 10: 40-68 Google Scholar , 4 Lau C.G. Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007; 8: 413-426 Google Scholar ). The initial evidence has emerged from administration of NMDAR antagonists, including phencyclidine and ketamine, which elicit psychotic symptoms and cognitive dysfunction similar to those of schizophrenia and related psychiatric disorders and aggravate the psychotic symptoms in patients with the disorders. The effects of NMDAR antagonists persist in the absence of activity of monoamines. Additionally, genetically reducing NMDAR expression in interneurons produces schizophrenia-like phenotypes. Finally, more recent genetic studies have linked numerous genes, including the disrupted in schizophrenia 1 gene (DISC1), with the disorders, and many of those molecules have been implicated in regulation of glutamatergic transmission ( 3 Harrison P.J. Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry. 2005; 10: 40-68 Google Scholar , 4 Lau C.G. Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci. 2007; 8: 413-426 Google Scholar ). Together, these findings have led to the prevailing hypothesis that hypofunction of NMDARs, particularly hypofunction of NMDARs in interneurons, causes progression and symptoms of schizophrenia and related psychiatric disorders. Regulation of N-Methyl-D-Aspartate Receptors by Disrupted-in-Schizophrenia-1Biological PsychiatryVol. 75Issue 5PreviewGenetic studies have implicated disrupted-in-schizophrenia-1 (DISC1) as a risk factor for a wide range of mental conditions, including schizophrenia. Because N-methyl-D-aspartate receptor (NMDAR) dysfunction has been strongly linked to the pathophysiology of these conditions, we examined whether the NMDAR is a potential target of DISC1. Full-Text PDF

Interplay Between a Mental Disorder Risk Gene and Developmental Polarity Switch of GABA Action Leads to Excitation-Inhibition Imbalance

Interplay Between DISC1 and GABA Signaling Regulates Neurogenesis in Mice and Risk for Schizophrenia

GABAergic neuron dysregulation in a human neurodevelopmental model for major psychiatric disorders

Interaction Between Fez1 and Disc1 in Regulation of Neuronal Development and Risk for Schizophrenia

DISC1 Dynamically Regulates Synaptic N-Methyl-D-Aspartate Responses in Excitatory Neurons

A Prenatal Interruption of DISC1 Function in the Brain Exhibits a Lasting Impact on Adult Behaviors, Brain Metabolism, and Interneuron Development

DISC1 Regulates Neurogenesis via Modulating Kinetochore Attachment of Ndel1/Nde1 during Mitosis

Disrupted-In-Schizophrenia 1 Regulates Integration of Newly Generated Neurons in the Adult Brain.

Alteration of Neuronal Excitability and Short-Term Synaptic Plasticity in the Prefrontal Cortex of a Mouse Model of Mental Illness.

Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia

Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation

Structural Interaction Between DISC1 and ATF4 Underlying Transcriptional and Synaptic Dysregulation in an Ipsc Model of Mental Disorders

Neuregulin 1 Promotes Excitatory Synapse Development and Function in Gabaergic Interneurons

Disc1 and Slc12a2 Interaction Affects Human Hippocampal Function and Connectivity

Defined co-cultures of glutamatergic and GABAergic neurons with a mutation in DISC1 reveal aberrant phenotypes in GABAergic neurons

Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation.

Specific Developmental Disruption Of Disrupted-In-Schizophrenia-1 Function Results In Schizophrenia-Related Phenotypes In Mice

NMDARs Drive the Expression of Neuropsychiatric Disorder Risk Genes Within GABAergic Interneuron Subtypes in the Juvenile Brain

Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders

Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics